1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow LYZZ Alpha Holding Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759 AZD3759 - Non Small Cell Lung Cancer | Phase 1 / Phase 2 | Completed | LYZZ Alpha Holding Ltd | 15 | 2017-10-30 | 2022-11-25 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
AZD3759 (1)
China (1)